|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||18.97 - 19.45|
|52-week range||12.13 - 20.94|
|Beta (5Y monthly)||0.83|
|PE ratio (TTM)||N/A|
|Earnings date||23 Oct 2023|
|Forward dividend & yield||N/A (N/A)|
|Ex-dividend date||11 May 2023|
|1y target est||19.50|
Philips (PHG) expands its mobile C-arm lineup with Zenition 30, which provides surgeons with more control and customization.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Philips Zenition 30 in use Philips Zenition 30 product photo September 13, 2023 Offering surgeons greater flexibility, control, and personalization in C-arm operation and image acquisition, Philips’ new Zenition 30 reduces dependency on technician support for a wide variety of minimally invasive procedures Advanced imaging algorithms contribute to outstanding image quality and dose efficiency Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology,